Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Detalles Bibliográficos
Autores principales: Barrett, Jordan R., Belij-Rammerstorfer, Sandra, Dold, Christina, Ewer, Katie J., Folegatti, Pedro M., Gilbride, Ciaran, Halkerston, Rachel, Hill, Jennifer, Jenkin, Daniel, Stockdale, Lisa, Verheul, Marije K., Aley, Parvinder K., Angus, Brian, Bellamy, Duncan, Berrie, Eleanor, Bibi, Sagida, Bittaye, Mustapha, Carroll, Miles W., Cavell, Breeze, Clutterbuck, Elizabeth A., Edwards, Nick, Flaxman, Amy, Fuskova, Michelle, Gorringe, Andrew, Hallis, Bassam, Kerridge, Simon, Lawrie, Alison M., Linder, Aline, Liu, Xinxue, Madhavan, Meera, Makinson, Rebecca, Mellors, Jack, Minassian, Angela, Moore, Maria, Mujadidi, Yama, Plested, Emma, Poulton, Ian, Ramasamy, Maheshi N., Robinson, Hannah, Rollier, Christine S., Song, Rinn, Snape, Matthew D., Tarrant, Richard, Taylor, Stephen, Thomas, Kelly M., Voysey, Merryn, Watson, Marion E. E., Wright, Daniel, Douglas, Alexander D., Green, Catherine M., Hill, Adrian V. S., Lambe, Teresa, Gilbert, Sarah, Pollard, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101331/
https://www.ncbi.nlm.nih.gov/pubmed/33958800
http://dx.doi.org/10.1038/s41591-021-01372-z

Ejemplares similares

Ejemplares similares